Latest Report Available at Analytical Research Cognizance Neuromodulation Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.
Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.
North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.
Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.
Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.
Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021. The report also entails major drivers and challenges of neuromodulation market.
Request a sample of this report @ http://www.arcognizance.com/enquiry-sample/1013
Neuromodulation Market: Segmentation
Neuromodulation market is classified on the basis of technology, application, company and geography.
Based on Technology, Neuromodulation market can be segmented as follows:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Based on Application, Neuromodulation market can be segmented as follows:
Urinary Fecal Incontinence
Treatment Resistant Depression(TRD)
Obsessive Compulsive Disorder(OCD)
Based on Geography, Neuromodulation market can be segmented as follows:
Rest of the World (ROW)
Based on Company, Neuromodulation market can be segmented as follows:
St Jude Medical
Purchase copy of this Report @ http://www.arcognizance.com/purchase/1013
Some Points from TOC:
- Executive Summary
- Global – Neuromodulation Market & Forecast (2010 – 2021)
- Global – Neuromodulation Market Share Outlook
3.1 By Technology – Neuromodulation Market Share Outlook
3.2 By Region – Neuromodulation Market Share Outlook
3.3 By Application – Neuromodulation Market Share Outlook
3.4 By Company – Neuromodulation Market Share Outlook
- Global Neuromodulation Market – By Technology (2010 – 2021)
4.1 Overall Neuromodulation Market & Forecast – By Technology
4.2 Spinal Cord Stimulation Market Revenue & Forecast
4.3 Deep Brain Stimulation Market Revenue & Forecast
4.4 Sacral Nerve Stimulation Market Revenue & Forecast
4.5 Vagus Nerve Stimulation Market Revenue & Forecast
4.6 Other Technologies Market Revenue & Forecast
- Global Neuromodulation Market – By Regional Outlook (2010 – 2021)
5.1 Region wise – Overall Neuromodulation Market Revenue & Forecast
5.2 North America – Neuromodulation Market Revenue & Forecast
5.3 Europe – Neuromodulation Market Revenue & Forecast
5.4 Asia Pacific – Neuromodulation Market Revenue & Forecast
5.5 Latin America – Neuromodulation Market Revenue & Forecast
5.6 Rest of the World (ROW) – Neuromodulation Market Revenue & Forecast
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics” based on the data collection facilities of big data, the face of “business research facilities” has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the “out of the box” developments in the market.
Name: Analytical research cognizance
Address: 100 Church Street,
8th floor, Manhattan,
New York 10007
Phone: +1 (646) 434-7969 +91 90967 44448